Cost-utility analysis of aprepitant for patients who truly need it in a Japanese health care setting.

被引：0
|
作者：
Tsukiyama, Ikuto
Ando, Masahiko
Tsukiyama, Sumiyo
Takeuchi, Masayuki
Ejiri, Masayuki
Yamamoto, Yoshihiro
Asai, Nobuhiro
Saito, Hiroko
Arakawa, Ichiro
Inoue, Tadao
Matsuura, Katsuhiko
Kubo, Akihito
机构：
[1] Aichi Med Univ Hosp, Dept Pharm, Nagakute, Aichi, Japan
[2] Nagoya Univ Hosp, Ctr Adv Med & Clin Res, Nagoya, Aichi, Japan
[3] Aichi Med Univ, Div Resp Med & Allergol, Sch Med, Aichi, Japan
[4] Meijo Univ, Fac Pharm, Nagoya, Aichi, Japan
[5] Teikyo Heisei Univ, Fac Pharmaceut Sci, Tokyo, Japan
[6] Ohu Univ, Sch Pharmaceut Sci, Fukushima, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.e18243
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18243
引用
收藏
页数：4
相关论文
共 50 条
  • [31] COST-UTILITY ANALYSIS OF ANTIHYPERTENSIVE DOSAGE ADJUSTMENTS BY A PHARMACIST IN A COMMUNITY SETTING
    Houde, F.
    Lachaine, J.
    VALUE IN HEALTH, 2017, 20 (09) : A502 - A502
  • [32] Cost-utility analysis of evolocumab in patients with ASCVD in Italy
    Marcellusi, Andrea
    Bini, Chiara
    Rotundo, Maria Assunta
    Arcangeli, Emanuela
    Martinez, Laura
    Vilela, Francesc Sorio
    Mennini, Francesco Saverio
    GLOBAL & REGIONAL HEALTH TECHNOLOGY ASSESSMENT, 2021, 8 : 155 - 167
  • [33] Cost-utility analysis of the rehabilitation of patients with musculoskeletal problems
    Jonsson D.
    Husberg M.
    Götherström U.
    International Advances in Economic Research, 2000, 6 (4) : 741 - 748
  • [34] Person-centred care for patients with chronic heart failure - a cost-utility analysis
    Hansson, Elisabeth
    Ekman, Inger
    Swedberg, Karl
    Wolf, Axel
    Dudas, Kerstin
    Ehlers, Lars
    Olsson, Lars-Eric
    EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING, 2016, 15 (04) : 276 - 284
  • [35] Cost-utility analysis of patient care in children with meningeal signs
    Oostenbrink, R
    Oostenbrink, JB
    Moons, KGM
    Derksen-Lubsen, G
    Essink-Bot, ML
    Grobbee, DE
    Redekop, WK
    Moll, HA
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2002, 18 (03) : 485 - 496
  • [36] Cost-utility analysis of an integrated care model for multimorbid patients based on a clinical trial
    Lanzeta, Itziar
    Mar, Javier
    Arrospide, Arantzazu
    GACETA SANITARIA, 2016, 30 (05) : 352 - 358
  • [37] Cost-utility analysis of tiotropium versus usual care in patients with COPD in the UK and Belgium
    Hettle, Robert
    Wouters, Hanne
    Ayres, Jon
    Gani, Ray
    Kelly, Steve
    Lion, Michaela
    Decramer, Marc
    RESPIRATORY MEDICINE, 2012, 106 (12) : 1722 - 1733
  • [38] A Review on Cost-Effectiveness and Cost-Utility of Psychosocial Care in Cancer Patients
    Jansen, Femke
    van Zwieten, Valesca
    Coupe, Veerle M. H.
    Leemans, C. Rene
    Leeuw, Irma M. Verdonck-de
    ASIA-PACIFIC JOURNAL OF ONCOLOGY NURSING, 2016, 3 (02) : 125 - 136
  • [39] A cost-utility analysis of nilotinib for CML patients who have become resistant to imatinib.
    Pilgrim, H.
    Jewitt, K.
    Ward, S.
    BLOOD, 2007, 110 (11) : 376B - 376B
  • [40] Cost-utility analysis in depression: The McSad utility measure for depression health states
    Bennett, KJ
    Torrance, GW
    Boyle, MH
    Guscott, R
    PSYCHIATRIC SERVICES, 2000, 51 (09) : 1171 - 1176
12345